{"id":309953,"date":"2026-10-15T10:47:57","date_gmt":"2026-10-15T05:17:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=309953"},"modified":"2026-10-15T10:47:57","modified_gmt":"2026-10-15T05:17:57","slug":"why-beta-drugs-ltd-share-price-rise-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/","title":{"rendered":"Beta Drugs (BETA) Share Price rises 8.6% to Rs 1,845.7"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\">Beta Drugs Ltd. (BETA)<\/a> share price rose to Rs 1,845.7 today, up 8.6% from the previous close. Market cap was Rs 1,865.81 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\"><strong>Beta Drugs Share Price<\/strong> rose 8.6% to Rs 1,845.7, with market capitalisation at Rs 1,865.81 crore as of 15 October 2026 at 10:45:45 AM IST.<\/p>\n<p><strong>Beta Drugs Share Price<\/strong> is rising today after the stock moved to Rs 1,845.7 from a previous close of Rs 1,699.5. The move leaves the company with a market capitalisation of Rs 1,865.81 crore, which places Beta Drugs Ltd. in the healthcare space as a Pharmaceuticals &amp; Drugs name. Univest figures confirm the price action, but they do not point to a specific company trigger.<\/p>\n<p>The Beta Drugs Share Price update matters because the stock is trading well above its previous close, while the day\u2019s range shows movement between Rs 1,674.2 and Rs 1,870. For readers tracking Beta Drugs Stock News, the verified facts point to a clear same-day share price gain rather than an assumed trigger. In the absence of a stated company-specific reason, the best interpretation is to read the move together with Beta Drugs Fundamental Analysis, valuation ratios and the healthcare sector benchmark. Univest data also shows the stock\u2019s exact market cap, which helps set the company\u2019s scale before looking at its ratios and peer context. Investors watching Beta Drugs Share Price Today can monitor whether the current price holds near the upper end of the day\u2019s range and how the stock compares with listed pharmaceutical peers.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Beta_Drugs_Share_Price_Today_Price_Action_Analysis\" title=\"Beta Drugs Share Price Today: Price Action Analysis\">Beta Drugs Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Beta_Drugs_Ltd_BETA_Fundamental_Analysis\" title=\"Beta Drugs Ltd. (BETA) Fundamental Analysis\">Beta Drugs Ltd. (BETA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Why_Investors_Are_Watching_Beta_Drugs\" title=\"Why Investors Are Watching Beta Drugs\">Why Investors Are Watching Beta Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#About_Beta_Drugs_Ltd\" title=\"About Beta Drugs Ltd.\">About Beta Drugs Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Why_is_Beta_Drugs_Share_Price_rising_today\" title=\"Why is Beta Drugs Share Price rising today?\">Why is Beta Drugs Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#What_is_Beta_Drugs_Share_Price_today\" title=\"What is Beta Drugs Share Price today?\">What is Beta Drugs Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#What_is_Beta_Drugs_market_capitalisation\" title=\"What is Beta Drugs market capitalisation?\">What is Beta Drugs market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#How_does_Beta_Drugs_Share_Price_compare_with_its_PE_ratio\" title=\"How does Beta Drugs Share Price compare with its P\/E ratio?\">How does Beta Drugs Share Price compare with its P\/E ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Is_Beta_Drugs_expensive_compared_with_peers\" title=\"Is Beta Drugs expensive compared with peers?\">Is Beta Drugs expensive compared with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#What_do_Beta_Drugs_ROE_and_ROCE_show\" title=\"What do Beta Drugs ROE and ROCE show?\">What do Beta Drugs ROE and ROCE show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#What_is_Beta_Drugs_EPS_and_book_value\" title=\"What is Beta Drugs EPS and book value?\">What is Beta Drugs EPS and book value?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Does_Beta_Drugs_pay_a_dividend\" title=\"Does Beta Drugs pay a dividend?\">Does Beta Drugs pay a dividend?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-beta-drugs-ltd-share-price-rise-today-2026\/#Track_Beta_Drugs_Share_Price_on_Univest\" title=\"Track Beta Drugs Share Price on Univest\">Track Beta Drugs Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Beta_Drugs_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Beta Drugs Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,845.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,699.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 146.2 (+8.6%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,700<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,870<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,674.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,865.81 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Small Cap<\/td>\n<\/tr>\n<\/table>\n<p>Beta Drugs Ltd. (BETA) rose to Rs 1,845.7 from the previous close of Rs 1,699.5, a move of Rs 146.2 or 8.6%. The stock opened at Rs 1,700, reached a high of Rs 1,870, recorded a low of Rs 1,674.2.<\/p>\n<p><strong>Beta Drugs Share Price<\/strong> opened at Rs 1,700, touched a high of Rs 1,870 and a low of Rs 1,674.2, and last traded at Rs 1,845.7. The price rise from the previous close of Rs 1,699.5 to the current price of Rs 1,845.7 is Rs 146.2, or 8.6%.<\/p>\n<p>The move gives Beta Drugs Share Price Today a firmly higher tone in the current market update. The stock is trading near the top of the day\u2019s range, which is a straightforward price action fact rather than a judgment on demand or conviction. In Beta Drugs Stock Performance terms, the gain stands out against the previous close and the opening level, while the market capitalisation remains at Rs 1,865.81 crore. For readers following Beta Drugs Share Price Live, the useful takeaway is simple: the stock is materially above the prior session reference, and the day\u2019s movement has been sustained across a broad intraday band. The next layer of Beta Drugs Stock Analysis comes from fundamentals, where valuation and returns help frame the move.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Beta_Drugs_Ltd_BETA_Fundamental_Analysis\"><\/span><strong>Beta Drugs Ltd. (BETA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,865.81 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.95%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.23%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 37.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 235.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Beta Drugs Ltd. (BETA) fundamental metrics show P\/E 45.56x, P\/B 7.21x, ROE 23.95%, ROCE 25.23%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>Beta Drugs Ltd. has a market capitalisation of Rs 1,865.81 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 45.56x, P\/B at 7.21x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.95% and ROCE of 25.23%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 37.3, book value per share of Rs 235.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 31.35x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.13x to 654.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.95%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.23%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.46%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,865.81 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 827.89 crore<\/td>\n<\/tr>\n<\/table>\n<p>Beta Drugs Ltd. (BETA) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Beta Drugs Ltd. (BETA) has a P\/E ratio of 45.56x, which is above the benchmark median of 31.35x, a difference of +45.33%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Beta Drugs Ltd. (BETA) has a ROE of 23.95%, which is above the benchmark median of 11.61%, a difference of +106.29%. Beta Drugs Ltd. (BETA) has a ROCE of 25.23%, which is above the benchmark median of 13.46%, a difference of +87.44%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,24,466.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,222.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">81.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,76,300.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">80.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,817.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,823.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">100.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Beta Drugs Ltd. (BETA) has a P\/E ratio of 45.56x compared with the displayed peer median of 80.12x. The comparison is relative and should not be read as a recommendation. Its ROE of 23.95% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 25.23% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Beta Drugs Ltd. (BETA) has a market capitalisation of Rs 1,865.81 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Beta_Drugs\"><\/span><strong>Why Investors Are Watching Beta Drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Beta Drugs Share Price<\/strong> is up 8.6% today, with the current price at Rs 1,845.7 and the previous close at Rs 1,699.5.<\/li>\n<li>The day\u2019s range, from Rs 1,674.2 to Rs 1,870, gives a clear price action frame for Beta Drugs Share Price Today.<\/li>\n<li>ROE of 23.95% and ROCE of 25.23% keep Beta Drugs Fundamental Analysis relevant for market participants.<\/li>\n<li>P\/E of 45.56 and P\/B of 7.21 place Beta Drugs Share Price on the richer side versus the same-industry median.<\/li>\n<li>Beta Drugs Market Cap of Rs 1,865.81 crore sits above the sector median and gives the stock a defined healthcare peer context.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Beta_Drugs_Ltd\"><\/span><strong>About Beta Drugs Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Beta Drugs Share Price<\/strong> belongs to Beta Drugs Ltd., a company in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The business operates within a segment where company scale, returns and valuation are often read together, so Beta Drugs Stock Analysis is naturally linked to its financial ratios. The company\u2019s market capitalisation of Rs 1,865.81 crore indicates its current market size, while the reported EPS of Rs 37.3 and book value of Rs 235.8 help frame the accounting and earnings base behind Beta Drugs Share Price. Dividend yield is 0%, so the current ratio set does not indicate a cash payout element. For readers following Beta Drugs Company News or Beta Drugs Stock Performance, the key company-level context is that it is a pharmaceuticals and drugs name with return ratios that are above the industry benchmark median. Univest tracks that profile because healthcare stocks often move when price action and valuation stand out together.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Beta_Drugs_Share_Price_rising_today\"><\/span><strong>Why is Beta Drugs Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs Share Price is rising today because the stock moved from Rs 1,699.5 to Rs 1,845.7, an 8.6% gain. Univest figures confirm the price action, but they do not point to a specific company trigger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Beta_Drugs_Share_Price_today\"><\/span><strong>What is Beta Drugs Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs Share Price today is Rs 1,845.7. The stock is trading above its previous close of Rs 1,699.5, which shows a clear same-day price rise in the latest Univest figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Beta_Drugs_market_capitalisation\"><\/span><strong>What is Beta Drugs market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs has a market capitalisation of Rs 1,865.81 crore. That places the company above the same-industry median market cap of Rs 827.89 crore, based on the healthcare benchmark set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Beta_Drugs_Share_Price_compare_with_its_PE_ratio\"><\/span><strong>How does Beta Drugs Share Price compare with its P\/E ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs Share Price is backed by a P\/E ratio of 45.56. That is above the industry median of 31.35 and slightly below the industry average of 46.92 across the benchmark set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Beta_Drugs_expensive_compared_with_peers\"><\/span><strong>Is Beta Drugs expensive compared with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs trades at a P\/B of 7.21 and a P\/E of 45.56. Both are above several listed peers such as Zydus Lifesciences, Cipla and Dr. Reddy\u2019s, so the valuation sits on the richer side.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Beta_Drugs_ROE_and_ROCE_show\"><\/span><strong>What do Beta Drugs ROE and ROCE show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs reports ROE of 23.95% and ROCE of 25.23%. Both are above the same-industry median and average, which adds useful context to Beta Drugs Fundamental Analysis and the current share price move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Beta_Drugs_EPS_and_book_value\"><\/span><strong>What is Beta Drugs EPS and book value?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs EPS is Rs 37.3 and book value is Rs 235.8. EPS shows earnings attributable to each share, while book value per share shows the accounting net worth behind each share.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Beta_Drugs_pay_a_dividend\"><\/span><strong>Does Beta Drugs pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Beta Drugs has a dividend yield of 0. That means the current figure set does not show a dividend income yield, so Beta Drugs Share Price is being assessed mainly on earnings and returns.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Beta Drugs Share Price rising today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Beta Drugs Share Price is rising today because the stock moved from Rs 1,699.5 to Rs 1,845.7, an 8.6% gain. Univest figures confirm the price action, but they do not point to a specific company trigger.\"}},{\"@type\":\"Question\",\"name\":\"What is Beta Drugs Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Beta Drugs Share Price today is Rs 1,845.7. The stock is trading above its previous close of Rs 1,699.5, which shows a clear same-day price rise in the latest Univest figures.\"}},{\"@type\":\"Question\",\"name\":\"What is Beta Drugs market capitalisation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Beta Drugs has a market capitalisation of Rs 1,865.81 crore. That places the company above the same-industry median market cap of Rs 827.89 crore, based on the healthcare benchmark set.\"}},{\"@type\":\"Question\",\"name\":\"How does Beta Drugs Share Price compare with its P\/E ratio?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Beta Drugs Share Price is backed by a P\/E ratio of 45.56. That is above the industry median of 31.35 and slightly below the industry average of 46.92 across the benchmark set.\"}},{\"@type\":\"Question\",\"name\":\"Is Beta Drugs expensive compared with peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Beta Drugs trades at a P\/B of 7.21 and a P\/E of 45.56. Both are above several listed peers such as Zydus Lifesciences, Cipla and Dr. Reddy\u2019s, so the valuation sits on the richer side.\"}},{\"@type\":\"Question\",\"name\":\"What do Beta Drugs ROE and ROCE show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Beta Drugs reports ROE of 23.95% and ROCE of 25.23%. Both are above the same-industry median and average, which adds useful context to Beta Drugs Fundamental Analysis and the current share price move.\"}},{\"@type\":\"Question\",\"name\":\"What is Beta Drugs EPS and book value?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Beta Drugs EPS is Rs 37.3 and book value is Rs 235.8. EPS shows earnings attributable to each share, while book value per share shows the accounting net worth behind each share.\"}},{\"@type\":\"Question\",\"name\":\"Does Beta Drugs pay a dividend?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Beta Drugs has a dividend yield of 0. That means the current figure set does not show a dividend income yield, so Beta Drugs Share Price is being assessed mainly on earnings and returns.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Beta_Drugs_Share_Price_on_Univest\"><\/span><strong>Track Beta Drugs Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\">Beta Drugs Ltd. (BETA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p><strong>Beta Drugs Share Price<\/strong> can be tracked on Univest alongside live price updates, fundamental ratios, 52-week levels and market insights. For investors reviewing Beta Drugs Share Price Today or Beta Drugs Share Price Live, the platform keeps the key numbers in one place. Univest also helps compare Beta Drugs Stock News with sector and peer context, which is useful when a same-day price rise appears without a stated company-specific catalyst. That makes Beta Drugs Share Price easier to follow through both price action and fundamentals.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beta Drugs Ltd. Share Price rises to Rs 1,845.7, marking an 8.6% rise today. Market cap stands at Rs 1,865.81 crore.<\/p>\n","protected":false},"author":35,"featured_media":309952,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-309953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["309952"],"rank_math_title":["Beta Drugs Share Price gains as fundamentals stay strong"],"rank_math_description":["Beta Drugs Share Price rose 8.6% to Rs 1,845.7. See price action, valuation ratios, sector comparison and peer context in this update."],"rank_math_focus_keyword":["Beta Drugs Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Beta_Drugs_BETA_Share_Price_rises_86_to_Rs_18457_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/309953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=309953"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/309953\/revisions"}],"predecessor-version":[{"id":309954,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/309953\/revisions\/309954"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/309952"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=309953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=309953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=309953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}